TITLE

Approaches to the Design of Effective HIV-1 Protease Inhibitors

AUTHOR(S)
Lebon, F.; Ledecq, M.
PUB. DATE
April 2000
SOURCE
Current Medicinal Chemistry;Apr2000, Vol. 7 Issue 4, p455
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Recently, western countries have recorded a decrease in the death rate imputed to AIDS. This success has been largely attributed to the presence on the market of chemotherapies that inhibit the infectivity of the predominant causative agent, the HIV-1 virus, by targeting essential viral enzymes. One of these is the protease (HIV-1 PR) whose activity is a prerequisite for viral replication. Two main sites have been identified as poten-tial targets for the inhibition of HIV-1 PR, the active site and the interface, the latter being largely responsible for the stabilization of the enzyme dimeric structure. The compounds that have reached clinical application so far target the active site of HIV-1 PR. These molecules act as transition state analogues and result from modifications of the peptidic scaffold into peptidomimetics. In order to improve their bioavailability, systematic biological screening and de novo design have been used to suggest new non-peptide inhibitors combining both antiviral potency and favorable pharmacokinetic properties. In parallel, compounds targeting other potential sites of inhibition have been tested. Peptides and peptidomimetics based on the terminal sequence of the enzyme, a site which is proposed to be less susceptible to mutations, have been shown to lead to HIV-1 PR inactivation. Cupric ion was described to bind a sequence on the protease surface, which includes cysteine and histidine residues, leading to the inhibition of the enzyme. In the future, these non-active site inhibitors could provide an alternative in anti-HIV drug combination strategies.
ACCESSION #
11133847

 

Related Articles

  • Death drop.  // Advocate;04/15/97, Issue 731, p17 

    Reports that the number of deaths due to AIDS from January to June 1996 in the United States, decreased significantly for the first time since it was recognized. Statistics produced by the Centers for Disease Control and Prevention; What the decline was attributed to; Decrease in the number of...

  • HIV affects mortality patterns. Hutchings, Claire // Geographical (Campion Interactive Publishing);Oct94, Vol. 66 Issue 10, p9 

    Reports on the effect of AIDS on the pattern of mortality in England and Wales. Results of research published by the Office of Population Censuses & Surveys; Professional homosexual men in their middle years as victims; Number of HIV-related deaths; Forecast on the annual number of deaths from...

  • AIDS survival time has nearly doubled since 1984. Jacobson, Lisa P. // American Family Physician;8/1/1993, Vol. 48 Issue 2, p319 

    Reports on the doubling in 1992 of the survival time of individuals diagnosed with AIDS from that in 1991. Data from the Multicenter AIDS Cohort Study by the National Institute of Allergy and Infectious Diseases; Greatest gain in survival time as those with Pneumocystis carinii pneumonia.

  • Estudo da subnotificação dos casos de Aids em Alagoas (Brasil), 1999-2005. Rique, Juliana; Paes da Silva, Maria Dolores // Revista Ciência & Saúde Coletiva;2011, Vol. 16 Issue 2, p599 

    The under-reporting of Aids (Acquired Immune Deficiency Syndrome) cases makes it difficult and even impossible to plan means to control the epidemic. This study aims to check out the under-reporting of Aids cases from 1999 to 2005 in Alagoas (Brazil). The deaths certificates causes by Aids...

  • AIDS no longer a leading killer...  // FDA Consumer;Mar/Apr2000, Vol. 34 Issue 2, p2 

    Reports on the decline of death rate from AIDS in the United States in 1998. Comparison of the death rate from 1996 to 1997.

  • GRAPH EXERCISE.  // New York Times Upfront (Teacher's Edition);05/14/2001, Vol. 133 Issue 18, p5 

    Presents a graph exercise on the number of AIDS death in the United States and sub-Saharan Africa from years 1982 to 2000. Approximation of African death toll in 1990; Comparison of death in both countries with the advent of AZT drug; Estimation of 2003 death toll.

  • AIDS Deaths and New AIDS Cases in the U.S., 1985-2005.  // World Almanac & Book of Facts;2009, p1735 

    A chart is presented that lists AIDS deaths and new AIDS cases in the U.S. from 1985 to 2005.

  • AIDS TOPS THAI DEATH STATS.  // Bay Windows;9/13/2001, pN.PAG 

    Reports on AIDS as the leading cause of death in Thailand as of August 31, 2001. Percentage of AIDS-related deaths; Other leading causes of deaths in Thailand.

  • Chapter 1: A Manageable Catastrophe. Waal, Alex de // AIDS & Power: Why There is No Political Crisis Yet;2006, p1 

    Chapter 1 of the book "AIDS and Power: Why There Is No Political Crisis--Yet," is presented. It explores the socio-political impact of the African AIDS epidemic world over. Information is given that it has increased the mortality levels of adults in their prime, 20-40 years. However, it is...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics